Titan Pharmaceuticals, Inc. Total Liabilities
Titan Pharmaceuticals, Inc. had Total Liabilities of $263.00 thousand as of 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2025-08-14
- 2025-06-30: Liabilities $263.00K.
- 2025-03-31: Liabilities $279.00K.
- 2024-12-31: Liabilities $483.00K.
- 2024-09-30: Liabilities $371.00K.
| Period end | Liabilities |
|---|---|
| 2025-06-30 | $263.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $279.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $483.00K 10-Q · filed 2025-08-14 |
| 2024-09-30 | $371.00K 10-Q · filed 2025-01-03 |
| 2024-06-30 | $356.00K 10-Q · filed 2024-08-15 |
| 2024-03-31 | $559.00K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $1.44M 10-K · filed 2025-03-20 |
| 2023-09-30 | $1.87M 10-K · filed 2024-04-01 |
| 2023-06-30 | $1.85M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $2.48M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $2.69M 10-K · filed 2024-04-01 |
| 2022-09-30 | $2.73M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $2.65M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $2.44M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $2.86M 10-K · filed 2023-03-31 |
| 2021-09-30 | $2.14M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $2.76M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $3.84M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $4.55M 10-K · filed 2022-03-25 |
| 2020-09-30 | $8.91M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $8.20M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $7.99M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $8.09M 10-K · filed 2021-03-31 |
| 2019-09-30 | $7.96M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $7.33M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $8.38M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $7.26M 10-K · filed 2020-03-30 |
| 2018-09-30 | $6.37M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $5.93M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $6.14M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $8.05M 10-K/A · filed 2019-04-02 |
| 2017-09-30 | $8.70M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $1.88M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $2.47M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $5.48M 10-K · filed 2018-04-02 |
| 2016-09-30 | $8.27M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $7.62M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $6.52M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $6.30M 10-K · filed 2017-03-16 |
| 2015-09-30 | $5.99M 10-Q · filed 2015-11-16 |
| 2015-06-30 | $15.33M 10-Q · filed 2015-08-13 |
| 2015-03-31 | $14.20M 10-Q · filed 2015-05-13 |
| 2014-12-31 | $12.24M 10-K · filed 2016-03-15 |
| 2014-09-30 | $8.96M 10-Q · filed 2014-11-13 |
| 2014-06-30 | $10.79M 10-Q · filed 2014-08-13 |
| 2014-03-31 | $11.84M 10-Q · filed 2014-05-14 |
| 2013-12-31 | $12.66M 10-K · filed 2015-03-31 |
| 2013-09-30 | $14.50M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $14.76M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $26.58M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $47.95M 10-K · filed 2014-03-31 |
| 2012-09-30 | $37.88M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $33.05M 10-Q · filed 2012-08-09 |
| 2012-03-31 | $31.20M 10-Q · filed 2012-05-10 |
| 2011-12-31 | $30.30M 10-K · filed 2013-03-18 |
| 2011-09-30 | $24.10M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $25.83M 10-Q/A · filed 2011-08-17 |
| 2010-12-31 | $10.80M 10-K · filed 2012-03-15 |